{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T20:01:57Z","timestamp":1792180917204,"version":"4.4.0"},"reference-count":120,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T00:00:00Z","timestamp":1740096000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100010269","name":"Wellcome Trust","doi-asserted-by":"publisher","award":["223499\/Z\/22\/Z"],"award-info":[{"award-number":["223499\/Z\/22\/Z"]}],"id":[{"id":"10.13039\/100010269","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bjanaesthesia.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["British Journal of Anaesthesia"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1016\/j.bja.2025.02.012","type":"journal-article","created":{"date-parts":[[2025,3,20]],"date-time":"2025-03-20T00:31:10Z","timestamp":1742430670000},"page":"1717-1745","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"title":["Multimorbidity and analgesic-related harms: a systematic review"],"prefix":"10.1016","volume":"134","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5249-5442","authenticated-orcid":false,"given":"Christopher H.","family":"Grant","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0148-0766","authenticated-orcid":false,"given":"Heather","family":"Walker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8012-7348","authenticated-orcid":false,"given":"Karen N.","family":"Barnett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3387-2123","authenticated-orcid":false,"given":"Patrick B.","family":"Mark","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1563-8600","authenticated-orcid":false,"given":"Lesley A.","family":"Colvin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9100-1575","authenticated-orcid":false,"given":"Samira","family":"Bell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bja.2025.02.012_bib1","series-title":"Multimorbidity: clinical assessment and management","year":"2017"},{"key":"10.1016\/j.bja.2025.02.012_bib2","series-title":"Multimorbidity: a priority for global health research","year":"2018"},{"key":"10.1016\/j.bja.2025.02.012_bib3","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2023.101860","article-title":"Global and regional prevalence of multimorbidity in the adult population in community settings: a systematic review and meta-analysis","volume":"57","author":"Chowdhury","year":"2023","journal-title":"EClinicalMedicine"},{"key":"10.1016\/j.bja.2025.02.012_bib4","article-title":"Prevalence of multimorbidity in community settings: a systematic review and meta-analysis of observational studies","volume":"9","author":"Nguyen","year":"2019","journal-title":"J\u00a0Comorb"},{"key":"10.1016\/j.bja.2025.02.012_bib5","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/S0140-6736(12)60240-2","article-title":"Epidemiology of multimorbidity and implications for health care, research, and medical education: a cross-sectional study","volume":"380","author":"Barnett","year":"2012","journal-title":"Lancet"},{"key":"10.1016\/j.bja.2025.02.012_bib6","doi-asserted-by":"crossref","DOI":"10.1016\/j.arr.2019.04.005","article-title":"Multimorbidity and quality of life: systematic literature review and meta-analysis","volume":"53","author":"Makovski","year":"2019","journal-title":"Ageing Res Rev"},{"key":"10.1016\/j.bja.2025.02.012_bib7","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1186\/s12916-019-1305-x","article-title":"Relationship between multimorbidity, demographic factors and mortality: findings from the UK Biobank cohort","volume":"17","author":"Jani","year":"2019","journal-title":"BMC Med"},{"key":"10.1016\/j.bja.2025.02.012_bib8","volume":"20","year":"2023","journal-title":"PLoS Med"},{"key":"10.1016\/j.bja.2025.02.012_bib9","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1038\/s41572-022-00376-4","article-title":"Multimorbidity","volume":"8","author":"Skou","year":"2022","journal-title":"Nat Rev Dis Primers"},{"key":"10.1016\/j.bja.2025.02.012_bib10","article-title":"Prevalence of chronic pain in LTCs and multimorbidity: a cross-sectional study using UK Biobank","volume":"11","author":"McQueenie","year":"2021","journal-title":"J\u00a0Multimorb Comorb"},{"key":"10.1016\/j.bja.2025.02.012_bib11","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1186\/s12875-016-0468-1","article-title":"Association between multimorbidity patterns and chronic pain in elderly primary care patients: a cross-sectional observational study","volume":"17","author":"Scherer","year":"2016","journal-title":"BMC Fam Pract"},{"key":"10.1016\/j.bja.2025.02.012_bib12","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1007\/s40520-022-02094-z","article-title":"Italian guidelines on management of persons with multimorbidity and polypharmacy","volume":"34","author":"Onder","year":"2022","journal-title":"Aging Clin Exp Res"},{"key":"10.1016\/j.bja.2025.02.012_bib13","first-page":"E1","article-title":"Guiding principles for the care of older adults with multimorbidity: an approach for clinicians: American geriatrics society expert panel on the care of older adults with multimorbidity","volume":"60","year":"2012","journal-title":"J\u00a0Am Geriatr Soc"},{"key":"10.1016\/j.bja.2025.02.012_bib16","doi-asserted-by":"crossref","first-page":"179","DOI":"10.46747\/cfp.6803179","article-title":"PEER simplified chronic pain guideline: management of chronic low back, osteoarthritic, and neuropathic pain in primary care","volume":"68","author":"Korownyk","year":"2022","journal-title":"Can Fam Physician"},{"key":"10.1016\/j.bja.2025.02.012_bib17","first-page":"3045","article-title":"Association between multimorbid disease patterns and pain outcomes among a complex chronic care population in Canada","volume":"13","author":"Ferguson","year":"2020","journal-title":"J\u00a0Pain Res"},{"key":"10.1016\/j.bja.2025.02.012_bib18","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1186\/s12916-019-1427-1","article-title":"Representation of people with comorbidity and multimorbidity in clinical trials of novel drug therapies: an individual-level participant data analysis","volume":"17","author":"Hanlon","year":"2019","journal-title":"BMC Med"},{"key":"10.1016\/j.bja.2025.02.012_bib19","doi-asserted-by":"crossref","first-page":"5005","DOI":"10.1038\/s41467-023-40637-8","article-title":"Gabapentinoid consumption in 65 countries and regions from 2008 to 2018: a longitudinal trend study","volume":"14","author":"Chan","year":"2023","journal-title":"Nat Commun"},{"key":"10.1016\/j.bja.2025.02.012_bib20","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1111\/bcp.14415","article-title":"Ten-year trend of opioid and nonopioid analgesic use in the French adult population","volume":"87","author":"Daveluy","year":"2021","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.bja.2025.02.012_bib21","doi-asserted-by":"crossref","DOI":"10.1136\/openhrt-2016-000550","article-title":"Use of non-steroidal anti-inflammatory drugs in US adults: changes over time and by demographic","volume":"4","author":"Davis","year":"2017","journal-title":"Open Heart"},{"key":"10.1016\/j.bja.2025.02.012_bib22","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1186\/s12889-018-6019-z","article-title":"Epidemiology of non-steroidal anti-inflammatory drugs consumption in Spain. The MCC-Spain study","volume":"18","author":"G\u00f3mez-Acebo","year":"2018","journal-title":"BMC Public Health"},{"key":"10.1016\/j.bja.2025.02.012_bib23","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2021.101198","article-title":"Global consumption of prescription opioid analgesics between 2009-2019: a country-level observational study","volume":"42","author":"Jayawardana","year":"2021","journal-title":"EClinicalMedicine"},{"key":"10.1016\/j.bja.2025.02.012_bib24","doi-asserted-by":"crossref","first-page":"e335","DOI":"10.1016\/S2468-2667(22)00013-5","article-title":"Global, regional, and national trends in opioid analgesic consumption from 2015 to 2019: a longitudinal study","volume":"7","author":"Ju","year":"2022","journal-title":"Lancet Public Health"},{"key":"10.1016\/j.bja.2025.02.012_bib25","doi-asserted-by":"crossref","first-page":"2448","DOI":"10.1001\/jama.2018.18472","article-title":"Opioids for chronic noncancer pain: a systematic review and meta-analysis","volume":"320","author":"Busse","year":"2018","journal-title":"JAMA"},{"key":"10.1016\/j.bja.2025.02.012_bib26","doi-asserted-by":"crossref","first-page":"276","DOI":"10.7326\/M14-2559","article-title":"The effectiveness and risks of long-term opioid therapy for chronic pain: a systematic review for a National Institutes of Health Pathways to Prevention Workshop","volume":"162","author":"Chou","year":"2015","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.bja.2025.02.012_bib27","first-page":"CD011669","article-title":"Morphine for chronic neuropathic pain in adults","volume":"5","author":"Cooper","year":"2017","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.bja.2025.02.012_bib28","first-page":"CD012299","article-title":"High-dose opioids for chronic non-cancer pain: an overview of Cochrane Reviews","volume":"10","author":"Els","year":"2017","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.bja.2025.02.012_bib29","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1111\/add.13324","article-title":"Gabapentin misuse, abuse and diversion: a systematic review","volume":"111","author":"Smith","year":"2016","journal-title":"Addiction"},{"key":"10.1016\/j.bja.2025.02.012_bib30","doi-asserted-by":"crossref","DOI":"10.1016\/j.aprim.2021.102144","article-title":"A\u00a0systematic review and meta-analysis of the effectiveness and adverse events of gabapentin and pregabalin for sciatica pain","volume":"54","author":"Gim\u00e9nez-Campos","year":"2022","journal-title":"Aten Primaria"},{"key":"10.1016\/j.bja.2025.02.012_bib31","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1007\/s11096-022-01528-y","article-title":"The safety and efficacy of gabapentinoids in the management of neuropathic pain: a systematic review with meta-analysis of randomised controlled trials","volume":"45","author":"Meaadi","year":"2023","journal-title":"Int J Clin Pharm"},{"key":"10.1016\/j.bja.2025.02.012_bib32","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1007\/s40265-020-01432-7","article-title":"Abuse and misuse of pregabalin and gabapentin: a systematic review update","volume":"81","author":"Evoy","year":"2021","journal-title":"Drugs"},{"issue":"3","key":"10.1016\/j.bja.2025.02.012_bib33","first-page":"CD007938","article-title":"Gabapentin for chronic neuropathic pain and fibromyalgia in adults","author":"Moore","year":"2011","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.bja.2025.02.012_bib34","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1159\/000355268","article-title":"Gabapentinoid abuse in order to potentiate the effect of methadone: a survey among substance misusers","volume":"20","author":"Baird","year":"2014","journal-title":"Eur Addict Res"},{"key":"10.1016\/j.bja.2025.02.012_bib35","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.bja.2020.05.017","article-title":"Trends in gabapentinoid prescribing, co-prescribing of opioids and benzodiazepines, and associated deaths in Scotland","volume":"125","author":"Torrance","year":"2020","journal-title":"Br J Anaesth"},{"key":"10.1016\/j.bja.2025.02.012_bib36","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1186\/s12882-017-0673-8","article-title":"Non-steroidal anti-inflammatory drug induced acute kidney injury in the community dwelling general population and people with chronic kidney disease: systematic review and meta-analysis","volume":"18","author":"Zhang","year":"2017","journal-title":"BMC Nephrol"},{"key":"10.1016\/j.bja.2025.02.012_bib37","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1016\/S0140-6736(13)60900-9","article-title":"Vascular and upper gastrointestinal effects of non-steroidal anti-inflammatory drugs: meta-analyses of individual participant data from randomised trials","volume":"382","author":"Bhala","year":"2013","journal-title":"Lancet"},{"key":"10.1016\/j.bja.2025.02.012_bib38","doi-asserted-by":"crossref","first-page":"j1909","DOI":"10.1136\/bmj.j1909","article-title":"Risk of acute myocardial infarction with NSAIDs in real world use: bayesian meta-analysis of individual patient data","volume":"357","author":"Bally","year":"2017","journal-title":"BMJ"},{"key":"10.1016\/j.bja.2025.02.012_bib39","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1007\/BF03261999","article-title":"Individual NSAIDs and upper gastrointestinal complications: a systematic review and meta-analysis of observational studies (the SOS project)","volume":"35","author":"Castellsague","year":"2012","journal-title":"Drug Saf"},{"key":"10.1016\/j.bja.2025.02.012_bib40","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1001098","article-title":"Cardiovascular risk with non-steroidal anti-inflammatory drugs: systematic review of population-based controlled observational studies","volume":"8","author":"McGettigan","year":"2011","journal-title":"PLoS Med"},{"key":"10.1016\/j.bja.2025.02.012_bib41","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1111\/j.1532-5415.2010.02920.x","article-title":"Outcomes associated with opioid use in the treatment of chronic noncancer pain in older adults: a systematic review and meta-analysis","volume":"58","author":"Papaleontiou","year":"2010","journal-title":"J\u00a0Am Geriatr Soc"},{"key":"10.1016\/j.bja.2025.02.012_bib42","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1089\/jpm.2019.0260","article-title":"Multimorbidity and opioid prescribing in hospitalized older adults","volume":"23","author":"Schear","year":"2020","journal-title":"J\u00a0Palliat Med"},{"key":"10.1016\/j.bja.2025.02.012_bib43","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1093\/eurpub\/cky098","article-title":"Defining and measuring multimorbidity: a systematic review of systematic reviews","volume":"29","author":"Johnston","year":"2019","journal-title":"Eur J Public Health"},{"key":"10.1016\/j.bja.2025.02.012_bib44","doi-asserted-by":"crossref","first-page":"e587","DOI":"10.1016\/S2468-2667(21)00107-9","article-title":"Examining variation in the measurement of multimorbidity in research: a systematic review of 566 studies","volume":"6","author":"Ho","year":"2021","journal-title":"Lancet Public Health"},{"key":"10.1016\/j.bja.2025.02.012_bib45","doi-asserted-by":"crossref","first-page":"m160","DOI":"10.1136\/bmj.m160","article-title":"Measuring multimorbidity beyond counting diseases: systematic review of community and population studies and guide to index choice","volume":"368","author":"Stirland","year":"2020","journal-title":"BMJ"},{"key":"10.1016\/j.bja.2025.02.012_bib46","doi-asserted-by":"crossref","DOI":"10.1136\/bmjmed-2022-000247","article-title":"Measuring multimorbidity in research: delphi consensus study","volume":"1","author":"Ho","year":"2022","journal-title":"BMJ Med"},{"key":"10.1016\/j.bja.2025.02.012_bib47","doi-asserted-by":"crossref","first-page":"E157","DOI":"10.5888\/pcd16.190169","article-title":"Opioid-related hospitalization and its association with chronic diseases: findings from the National Inpatient Sample, 2011-2015","volume":"16","author":"Rajbhandari-Thapa","year":"2019","journal-title":"Prev Chronic Dis"},{"key":"10.1016\/j.bja.2025.02.012_bib48","doi-asserted-by":"crossref","first-page":"n71","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"key":"10.1016\/j.bja.2025.02.012_bib49","doi-asserted-by":"crossref","first-page":"i157","DOI":"10.1136\/bmj.i157","article-title":"PRISMA harms checklist: improving harms reporting in systematic reviews","volume":"352","author":"Zorzela","year":"2016","journal-title":"BMJ"},{"key":"10.1016\/j.bja.2025.02.012_bib50","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1016\/j.jclinepi.2008.06.007","article-title":"AHRQ series paper 4: assessing harms when comparing medical interventions: AHRQ and the effective health-care program","volume":"63","author":"Chou","year":"2010","journal-title":"J\u00a0Clin Epidemiol"},{"key":"10.1016\/j.bja.2025.02.012_bib51","series-title":"Cochrane handbook for systematic reviews of interventions version 6.4 (updated august 2023)","article-title":"Chapter 19: adverse effects","author":"Peryer","year":"2023"},{"key":"10.1016\/j.bja.2025.02.012_bib52","doi-asserted-by":"crossref","first-page":"199","DOI":"10.11613\/BM.2014.022","article-title":"Observational and interventional study design types; an overview","volume":"24","author":"Thiese","year":"2014","journal-title":"Biochem Med (Zagreb)"},{"key":"10.1016\/j.bja.2025.02.012_bib53","series-title":"Cochrane adverse effects methods group","article-title":"Adverse effects 2: searching for adverse effects","author":"Golder","year":"2017"},{"key":"10.1016\/j.bja.2025.02.012_bib54","series-title":"Covidence systematic review software","year":"2024"},{"key":"10.1016\/j.bja.2025.02.012_bib55","series-title":"The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses","author":"Wells","year":"2000"},{"key":"10.1016\/j.bja.2025.02.012_bib56","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1016\/j.jsams.2022.08.018","article-title":"Prevalence, frequency, adverse events, and reasons for analgesic use in youth athletes: a systematic review and meta-analysis of 44,381 athletes","volume":"25","author":"Pedersen","year":"2022","journal-title":"J\u00a0Sci Med Sport"},{"key":"10.1016\/j.bja.2025.02.012_bib57","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1002\/phar.2666","article-title":"Patient risk factors for opioid-related adverse drug events in hospitalized patients: a systematic review","volume":"42","author":"Yiu","year":"2022","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.bja.2025.02.012_bib58","doi-asserted-by":"crossref","first-page":"i4919","DOI":"10.1136\/bmj.i4919","article-title":"ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions","volume":"355","author":"Sterne","year":"2016","journal-title":"BMJ"},{"key":"10.1016\/j.bja.2025.02.012_bib59","series-title":"Cochrane handbook for systematic reviews of interventions version 6.4 (updated august 2023)","article-title":"Chapter 12: synthesizing and presenting findings using other methods","author":"McKenzie","year":"2023"},{"key":"10.1016\/j.bja.2025.02.012_bib60","first-page":"3103","article-title":"Mortality risks after two years in frail and pre-frail older adults admitted to hospital","volume":"12","author":"Cano-Escalera","year":"2023","journal-title":"J\u00a0Clin Med"},{"key":"10.1016\/j.bja.2025.02.012_bib61","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1016\/j.jpainsymman.2010.06.015","article-title":"Transdermal buprenorphine for the treatment of chronic noncancer pain in the oldest old","volume":"41","author":"Gianni","year":"2011","journal-title":"J\u00a0Pain Symptom Manage"},{"key":"10.1016\/j.bja.2025.02.012_bib62","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2019.2613","article-title":"Association between opioid dose variability and opioid overdose among adults prescribed long-term opioid therapy","volume":"2","author":"Glanz","year":"2019","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.bja.2025.02.012_bib63","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1186\/s12916-020-01644-4","article-title":"All-cause mortality in patients with long-term opioid therapy compared with non-opioid analgesics for chronic non-cancer pain: a database study","volume":"18","author":"H\u00e4user","year":"2020","journal-title":"BMC Med"},{"key":"10.1016\/j.bja.2025.02.012_bib64","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1002\/phar.1223","article-title":"Cost and quality implications of opioid-based postsurgical pain control using administrative claims data from a large health system: opioid-related adverse events and their impact on clinical and economic outcomes","volume":"33","author":"Kessler","year":"2013","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.bja.2025.02.012_bib65","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugpo.2023.103953","article-title":"A\u00a0population-based study on the risk of prescription opioid abuse in patients with chronic opioid use and cost-effectiveness of prescription drug monitoring program using a patient simulation model in South Korea","volume":"112","author":"Kim","year":"2023","journal-title":"Int J Drug Policy"},{"key":"10.1016\/j.bja.2025.02.012_bib66","article-title":"Atrial fibrillation is associated with morphine treatment in female breast cancer patients: a retrospective population-based time-dependent cohort study","volume":"95","author":"Lee","year":"2016","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.bja.2025.02.012_bib67","doi-asserted-by":"crossref","first-page":"1871","DOI":"10.1093\/pm\/pnz234","article-title":"Associations between the specialty of opioid prescribers and opioid addiction, misuse, and overdose outcomes","volume":"21","author":"Lobo","year":"2020","journal-title":"Pain Med"},{"key":"10.1016\/j.bja.2025.02.012_bib68","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1111\/jgs.15127","article-title":"Opiate prescribing in hospitalized older adults: patterns and outcomes","volume":"66","author":"Maiti","year":"2018","journal-title":"J\u00a0Am Geriatr Soc"},{"key":"10.1016\/j.bja.2025.02.012_bib69","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1001\/jamasurg.2018.1039","article-title":"Association of opioid-related adverse drug events with clinical and cost outcomes among surgical patients in a large integrated health care delivery system","volume":"153","author":"Shafi","year":"2018","journal-title":"JAMA Surg"},{"key":"10.1016\/j.bja.2025.02.012_bib70","article-title":"Emergency department utilization among people living with HIV on chronic opioid therapy","volume":"20","author":"Thakarar","year":"2021","journal-title":"J\u00a0Int Assoc Provid AIDS Care"},{"key":"10.1016\/j.bja.2025.02.012_bib71","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1186\/1471-2318-14-131","article-title":"Is use of fall risk-increasing drugs in an elderly population associated with an increased risk of hip fracture, after adjustment for multimorbidity level: a cohort study","volume":"14","author":"Thorell","year":"2014","journal-title":"BMC Geriatr"},{"key":"10.1016\/j.bja.2025.02.012_bib72","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2021.45691","article-title":"Factors associated with opioid overdose after an initial opioid prescription","volume":"5","author":"Weiner","year":"2022","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.bja.2025.02.012_bib73","article-title":"Prescription opioids are associated with higher mortality in patients diagnosed with sepsis: a retrospective cohort study using electronic health records","volume":"13","author":"Zhang","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.bja.2025.02.012_bib74","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1186\/s13075-022-02909-4","article-title":"Comorbidity phenotypes and risk of mortality in patients with osteoarthritis in the UK: a latent class analysis","volume":"24","author":"Zemedikun","year":"2022","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.bja.2025.02.012_bib75","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1136\/gut.2010.217281","article-title":"Concurrent drug use and the risk of perforated colonic diverticular disease: a population-based case-control study","volume":"60","author":"Humes","year":"2011","journal-title":"Gut"},{"key":"10.1016\/j.bja.2025.02.012_bib76","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1111\/j.1365-2036.2008.03706.x","article-title":"National mortality following upper gastrointestinal or cardiovascular events in older veterans with recent nonsteroidal anti-inflammatory drug use","volume":"28","author":"Abraham","year":"2008","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.bja.2025.02.012_bib77","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/j.semarthrit.2017.08.002","article-title":"Impact of anti-rheumatic treatment on cardiovascular risk in Asian patients with rheumatoid arthritis","volume":"47","author":"Cho","year":"2018","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.bja.2025.02.012_bib78","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1176\/appi.ajp.2012.11091325","article-title":"Antidepressant response in patients with major depression exposed to NSAIDs: a pharmacovigilance study","volume":"169","author":"Gallagher","year":"2012","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.bja.2025.02.012_bib79","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1111\/trf.15110","article-title":"Impact of preadmission anti-inflammatory drug use on the risk of RBC transfusion in elderly hip fracture patients: a Danish nationwide cohort study, 2005-2016","volume":"59","author":"Glassou","year":"2019","journal-title":"Transfusion"},{"key":"10.1016\/j.bja.2025.02.012_bib80","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1007\/s00268-021-06320-z","article-title":"Identification of risk factors for acute kidney injury from intravenous ketorolac in geriatric trauma patients","volume":"46","author":"Hall","year":"2022","journal-title":"World J Surg"},{"key":"10.1016\/j.bja.2025.02.012_bib81","article-title":"A\u00a0matched case-control study to assess the association between non-steroidal anti-inflammatory drug use and thrombotic microangiopathy","volume":"13","author":"Liu","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.bja.2025.02.012_bib82","first-page":"550","article-title":"Gastrointestinal bleeding rates among managed care patients newly started on cox-2 inhibitors or nonselective NSAIDs","volume":"11","author":"Stockl","year":"2005","journal-title":"J\u00a0Manag Care Pharm"},{"key":"10.1016\/j.bja.2025.02.012_bib83","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpsychores.2023.111212","article-title":"Anti-inflammatory medication use associated with reduced delirium risk and all-cause mortality: a retrospective cohort study","volume":"168","author":"Yamanashi","year":"2023","journal-title":"J\u00a0Psychosom Res"},{"key":"10.1016\/j.bja.2025.02.012_bib84","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1001\/jamainternmed.2022.3680","article-title":"Perioperative gabapentin use and in-hospital adverse clinical events among older adults after major surgery","volume":"182","author":"Park","year":"2022","journal-title":"JAMA Intern Med"},{"key":"10.1016\/j.bja.2025.02.012_bib85","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1002\/pds.5652","article-title":"Impact of hemoglobin A1c level on the association between non-steroidal anti-inflammatory drug use and cardiovascular events in patients with type 2 diabetes: a population-based cohort study","volume":"32","author":"Bonnesen","year":"2023","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"10.1016\/j.bja.2025.02.012_bib86","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1159\/000538074","article-title":"Short-term medication effect on fall risk in multimorbid inpatients with dementia","volume":"70","author":"Podesser","year":"2024","journal-title":"Gerontology"},{"key":"10.1016\/j.bja.2025.02.012_bib87","first-page":"133","article-title":"Impact of chronic pain on patients' quality of life: a comparative mixed-methods study","volume":"6","author":"Hadi","year":"2019","journal-title":"J\u00a0Patient Exp"},{"key":"10.1016\/j.bja.2025.02.012_bib88","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.ejpain.2005.06.009","article-title":"Survey of chronic pain in Europe: prevalence, impact on daily life, and treatment","volume":"10","author":"Breivik","year":"2006","journal-title":"Eur J Pain"},{"key":"10.1016\/j.bja.2025.02.012_bib89","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1370\/afm.2178","article-title":"A\u00a0core outcome set for multimorbidity research (COSmm)","volume":"16","author":"Smith","year":"2018","journal-title":"Ann Fam Med"},{"key":"10.1016\/j.bja.2025.02.012_bib90","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1111\/pme.12621","article-title":"The complexity model: a novel approach to improve chronic pain care","volume":"16","author":"Peppin","year":"2015","journal-title":"Pain Med"},{"key":"10.1016\/j.bja.2025.02.012_bib91","doi-asserted-by":"crossref","first-page":"410","DOI":"10.2165\/00003088-199631060-00002","article-title":"Pharmacokinetics of opioids in renal dysfunction","volume":"31","author":"Davies","year":"1996","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.bja.2025.02.012_bib92","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1097\/ALN.0000000000000768","article-title":"Psychiatric comorbidity is associated prospectively with diminished opioid analgesia and increased opioid misuse in patients with chronic low back pain","volume":"123","author":"Wasan","year":"2015","journal-title":"Anesthesiology"},{"key":"10.1016\/j.bja.2025.02.012_bib93","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1186\/s12916-024-03505-w","article-title":"The impact of adverse childhood experiences on multimorbidity: a systematic review and meta-analysis","volume":"22","author":"Senaratne","year":"2024","journal-title":"BMC Med"},{"key":"10.1016\/j.bja.2025.02.012_bib94","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1016\/j.bja.2023.03.008","article-title":"The effect of adverse childhood experiences on chronic pain and major depression in adulthood: a systematic review and meta-analysis","volume":"130","author":"Antoniou","year":"2023","journal-title":"Br J Anaesth"},{"key":"10.1016\/j.bja.2025.02.012_bib95","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1007\/s10935-020-00578-0","article-title":"Adverse childhood experiences increase risk for prescription opioid misuse","volume":"41","author":"Merrick","year":"2020","journal-title":"J\u00a0Prim Prev"},{"key":"10.1016\/j.bja.2025.02.012_bib96","doi-asserted-by":"crossref","first-page":"l6964","DOI":"10.1136\/bmj.l6964","article-title":"Rising to the challenge of multimorbidity","volume":"368","author":"Whitty","year":"2020","journal-title":"BMJ"},{"key":"10.1016\/j.bja.2025.02.012_bib97","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1003270","article-title":"Time trends and prescribing patterns of opioid drugs in UK primary care patients with non-cancer pain: a retrospective cohort study","volume":"17","author":"Jani","year":"2020","journal-title":"PLoS Med"},{"key":"10.1016\/j.bja.2025.02.012_bib98","doi-asserted-by":"crossref","first-page":"697","DOI":"10.15585\/mmwr.mm6626a4","article-title":"Vital signs: changes in opioid prescribing in the United States, 2006\u20132015","volume":"66","author":"Guy","year":"2017","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.bja.2025.02.012_bib99","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1016\/j.bja.2018.02.022","article-title":"Association of opioid prescribing practices with chronic pain and benzodiazepine co-prescription: a primary care data linkage study","volume":"120","author":"Torrance","year":"2018","journal-title":"Br J Anaesth"},{"key":"10.1016\/j.bja.2025.02.012_bib100","doi-asserted-by":"crossref","first-page":"721","DOI":"10.7326\/M19-3600","article-title":"Predictors of prolonged opioid use after initial prescription for acute musculoskeletal injuries in adults: a systematic review and meta-analysis of observational studies","volume":"173","author":"Riva","year":"2020","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.bja.2025.02.012_bib101","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1097\/AJP.0000000000000571","article-title":"Associations between early care decisions and the risk for long-term opioid use for patients with low back pain with a new physician consultation and initiation of opioid therapy","volume":"34","author":"Fritz","year":"2018","journal-title":"Clin J Pain"},{"key":"10.1016\/j.bja.2025.02.012_bib102","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.annemergmed.2018.06.003","article-title":"National variation in opioid prescribing and risk of prolonged use for opioid-naive patients treated in the emergency department for ankle sprains","volume":"72","author":"Delgado","year":"2018","journal-title":"Ann Emerg Med"},{"key":"10.1016\/j.bja.2025.02.012_bib103","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1002\/pmrj.12994","article-title":"Diagnostic profiles associated with long-term opioid therapy in active duty servicemembers","volume":"16","author":"Dufour","year":"2024","journal-title":"PM R"},{"key":"10.1016\/j.bja.2025.02.012_bib104","doi-asserted-by":"crossref","first-page":"2857","DOI":"10.1007\/s40520-021-01791-5","article-title":"The patterns and burden of multimorbidity in geriatric patients with prolonged use of addictive medications","volume":"33","author":"Cheng","year":"2021","journal-title":"Aging Clin Exp Res"},{"key":"10.1016\/j.bja.2025.02.012_bib105","first-page":"CD012509","article-title":"Adverse events associated with medium-and long-term use of opioids for chronic non-cancer pain: an overview of Cochrane Reviews","volume":"10","author":"Els","year":"2017","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.bja.2025.02.012_bib106","doi-asserted-by":"crossref","first-page":"407","DOI":"10.3122\/jabfm.2017.04.170112","article-title":"Prescription opioid use among adults with mental health disorders in the United States","volume":"30","author":"Davis","year":"2017","journal-title":"J\u00a0Am Board Fam Med"},{"key":"10.1016\/j.bja.2025.02.012_bib107","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/AJP.0b013e3181b99f35","article-title":"Trends in use of opioids for chronic noncancer pain among individuals with mental health and substance use disorders: the TROUP study","volume":"26","author":"Edlund","year":"2010","journal-title":"Clin J Pain"},{"key":"10.1016\/j.bja.2025.02.012_bib108","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1093\/geront\/gnaa016","article-title":"Unintended consequences of opioid regulations in older adults with multiple chronic conditions","volume":"60","author":"Ritchie","year":"2020","journal-title":"Gerontologist"},{"key":"10.1016\/j.bja.2025.02.012_bib109","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.jclinepi.2021.10.024","article-title":"Harms in Systematic Reviews Paper 2: methods used to assess harms are neglected in systematic reviews of gabapentin","volume":"143","author":"Qureshi","year":"2022","journal-title":"J\u00a0Clin Epidemiol"},{"key":"10.1016\/j.bja.2025.02.012_bib110","doi-asserted-by":"crossref","first-page":"f7668","DOI":"10.1136\/bmj.f7668","article-title":"Quality of reporting in systematic reviews of adverse events: systematic review","volume":"348","author":"Zorzela","year":"2014","journal-title":"BMJ"},{"key":"10.1016\/j.bja.2025.02.012_bib111","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/0021-9681(87)90171-8","article-title":"A\u00a0new method of classifying prognostic comorbidity in longitudinal studies: development and validation","volume":"40","author":"Charlson","year":"1987","journal-title":"J\u00a0Chronic Dis"},{"key":"10.1016\/j.bja.2025.02.012_bib112","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1370\/afm.1363","article-title":"Measures of multimorbidity and morbidity burden for use in primary care and community settings: a systematic review and guide","volume":"10","author":"Huntley","year":"2012","journal-title":"Ann Fam Med"},{"key":"10.1016\/j.bja.2025.02.012_bib113","article-title":"Systematic review on the instruments used for measuring the association of the level of multimorbidity and clinically important outcomes","volume":"11","author":"Lee","year":"2021","journal-title":"BMJ Open"},{"key":"10.1016\/j.bja.2025.02.012_bib114","doi-asserted-by":"crossref","first-page":"324","DOI":"10.5694\/mja2.50992","article-title":"The efficacy and safety of paracetamol for pain relief: an overview of systematic reviews","volume":"214","author":"Abdel","year":"2021","journal-title":"Med J Aust"},{"key":"10.1016\/j.bja.2025.02.012_bib115","article-title":"Incidence of side effects associated with acetaminophen in people aged 65 years or more: a prospective cohort study using data from the Clinical Practice Research Datalink","author":"Kaur","year":"2024","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"10.1016\/j.bja.2025.02.012_bib116","doi-asserted-by":"crossref","first-page":"2082","DOI":"10.1016\/S0140-6736(21)00393-7","article-title":"Chronic pain: an update on burden, best practices, and new advances","volume":"397","author":"Cohen","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.bja.2025.02.012_bib117","doi-asserted-by":"crossref","first-page":"3384","DOI":"10.2174\/1381612824666180327154239","article-title":"Association between drug burden index and functional and cognitive function in patients with multimorbidity","volume":"24","author":"Villalba-Moreno","year":"2018","journal-title":"Curr Pharm Des"},{"key":"10.1016\/j.bja.2025.02.012_bib118","article-title":"Exploring the impact of medication regimen complexity on health-related quality of life in patients with multimorbidity","volume":"2023","author":"Gebresillassie","year":"2023","journal-title":"J\u00a0Clin Pharm Ther"},{"key":"10.1016\/j.bja.2025.02.012_bib119","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1186\/s12877-020-01580-1","article-title":"Multimorbidity patterns, polypharmacy and their association with liver and kidney abnormalities in people over 65 years of age: a longitudinal study","volume":"20","author":"Vill\u00e9n","year":"2020","journal-title":"BMC Geriatr"},{"key":"10.1016\/j.bja.2025.02.012_bib120","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1186\/s12874-022-01768-6","article-title":"Real-world data: a brief review of the methods, applications, challenges and opportunities","volume":"22","author":"Liu","year":"2022","journal-title":"BMC Med Res Methodol"},{"key":"10.1016\/j.bja.2025.02.012_bib121","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1681\/ASN.0000000000000152","article-title":"Target trial emulation to improve causal inference from observational data: what, why, and how?","volume":"34","author":"Fu","year":"2023","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.bja.2025.02.012_bib122","article-title":"Multiple long-term conditions (multimorbidity): making sense of the evidence","author":"Imison","year":"2021","journal-title":"Natl Inst Health Res"}],"container-title":["British Journal of Anaesthesia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S000709122500114X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S000709122500114X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,2]],"date-time":"2026-05-02T03:55:59Z","timestamp":1777694159000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S000709122500114X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6]]},"references-count":120,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025,6]]}},"alternative-id":["S000709122500114X"],"URL":"https:\/\/doi.org\/10.1016\/j.bja.2025.02.012","relation":{},"ISSN":["0007-0912"],"issn-type":[{"value":"0007-0912","type":"print"}],"subject":[],"published":{"date-parts":[[2025,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Multimorbidity and analgesic-related harms: a systematic review","name":"articletitle","label":"Article Title"},{"value":"British Journal of Anaesthesia","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bja.2025.02.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Ltd on behalf of British Journal of Anaesthesia.","name":"copyright","label":"Copyright"}]}}